SI-BONE, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $23.16
- 52-Week Range
- $11.48 – $25.92
- Market Cap
- $1.06B
- P/E (TTM)
- —
- EPS (TTM)
- -0.31
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 5.74
- PEG Ratio
- —
- Return on Equity
- -7.67%
- Return on Assets
- -4.25%
- Gross Margin
- 79.40%
- Operating Margin
- -7.57%
- Profit Margin
- -6.20%
- Current Ratio
- 7.58
- Debt/Equity
- 0.23
- Total Debt
- $42.80M
- Free Cash Flow
- $-1.17M
- Revenue Growth
- 14.50%
- Earnings Growth
- —
- Enterprise Value
- $958.50M
Market Snapshot
About
SI-BONE is a medical device company that pioneered the iFuse Implant System for minimally invasive surgical treatment of the sacroiliac joint. The company focuses on addressing a significant source of lower back pain that is often underdiagnosed. SI-BONE markets its products to spine surgeons and orthopedic specialists worldwide.